Bain Capital Life Sciences Investors, Llc - Net Worth and Insider Trading

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 47,471 shares made by Ted Yednock , a net sale of 7,367 shares made by Jennifer Lew , and a net sale of 5,923 shares made by Michael Overdorf .

In summary, during the past 3 months, insiders sold 17,898 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 11,498 shares. During the past 18 months, 73,114 shares of Annexon Inc (ANNX) were sold and 3,303,458 shares were bought by its insiders, resulting in a net purchase of 3,230,344 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 42,938 shares made by Todd Franklin Watanabe , a net sale of 15,610 shares made by Masaru Matsuda , and a net sale of 37,403 shares made by Howard G. Welgus .

In summary, during the past 3 months, insiders sold 62,413 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 21,052 shares, with a net sale of 41,361 shares. During the past 18 months, 136,951 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 34,436 shares.

Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aptinyx Inc (APTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptinyx Inc (APTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aptinyx Inc (APTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in SpringWorks Therapeutics Inc (SWTX). Other recent insider transactions involving SpringWorks Therapeutics Inc (SWTX) include a net sale of 42,039 shares made by Daniel Pichl , a net sale of 4,818 shares made by Julie Hambleton , and a net sale of 1,750,000 shares made by Jeffrey Lawrence Schwartz .

In summary, during the past 3 months, insiders sold 15,000 shares of SpringWorks Therapeutics Inc (SWTX) in total and bought 0 shares, with a net sale of 15,000 shares. During the past 18 months, 1,804,913 shares of SpringWorks Therapeutics Inc (SWTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,804,913 shares.

SpringWorks Therapeutics Inc (SWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Replimune Group Inc (REPL). Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 66,624 shares made by Pamela Esposito , a net sale of 25,067 shares made by Tanya Lewis , and a net sale of 21,273 shares made by Sushil Patel .

In summary, during the past 3 months, insiders sold 0 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 174,192 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 174,192 shares.

Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Marinus Pharmaceuticals Inc (MRNS). Other recent insider transactions involving Marinus Pharmaceuticals Inc (MRNS) include a net sale of 6,443 shares made by Scott Braunstein , a net sale of 2,902 shares made by Joseph Hulihan , and a net sale of 2,804 shares made by Steven Pfanstiel .

In summary, during the past 3 months, insiders sold 0 shares of Marinus Pharmaceuticals Inc (MRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,566 shares of Marinus Pharmaceuticals Inc (MRNS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,566 shares.

Marinus Pharmaceuticals Inc (MRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Rapid Micro Biosystems Inc (RPID). Other recent insider transactions involving Rapid Micro Biosystems Inc (RPID) include a net purchase of 74,000 shares made by Spignesi Robert G. Jr. , and a net purchase of 10,000 shares made by Sean M Wirtjes .

In summary, during the past 3 months, insiders sold 0 shares of Rapid Micro Biosystems Inc (RPID) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rapid Micro Biosystems Inc (RPID) were sold and 84,000 shares were bought by its insiders, resulting in a net purchase of 84,000 shares.

Rapid Micro Biosystems Inc (RPID)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 485,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Solid Biosciences Inc (SLDB). Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 3,753 shares made by Ilan Ganot , a net purchase of 3,410,713 shares made by Perceptive Life Sciences Master Fund Ltd , and a net purchase of 904,160 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 462 shares of Solid Biosciences Inc (SLDB) in total and bought 0 shares, with a net sale of 462 shares. During the past 18 months, 26,233 shares of Solid Biosciences Inc (SLDB) were sold and 4,314,873 shares were bought by its insiders, resulting in a net purchase of 4,288,640 shares.

Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.